Metylenová modr v lécbĕ vazoplegického syndromu po kardiochirurgické operaci
[Methylene blue in the therapy of vasoplegic syndrome after cardiac surgery procedure]

. 2006 ; 145 (4) : 322-4.

Jazyk čeština Země Česko Médium print

Typ dokumentu kazuistiky, anglický abstrakt, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid16639934
Odkazy

PubMed 16639934

Vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass is severe complication with high morbidity and mortality. Without appropriate therapy the syndrome advances to the shock state with subsequent multiorgan failure. Basic haemodynamic parameters of vasoplegic syndrome include low systemic vascular resistance with severe hypotension, tachycardia, and normal or increased cardiac output and low filling pressures. In therapy norepinephrine and vasopressin or its analogues are used. Methylene blue is other therapeutic option. The case of successful application of methylene blue for the treatment of vasoplegic syndrome is presented.

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace